Karo Pharma SA (KARO)

Stockholm
Currency in SEK
60.70
0.00(0.00%)
Closed·
Showing Karo Pharma historical data. For real-time data please try another search
Day's Range
60.4061.00
52 wk Range
60.4061.00
Key Statistics
Edit
Prev. Close
60.5
Open
60.4
Day's Range
60.4-61
52 wk Range
60.4-61
Volume
-
Average Volume (3m)
242.43K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Karo Pharma SA Company Profile

Karo Healthcare AB develops and markets over-the-counter products and prescription drugs for pharmacies, digital distribution channels, and retail sector. It offers skin health products under the E45, Remescar, Locobase, Decubal, and indy beauty brand names; intimate health products under the Pevaryl, Multi Gyn, Asan, and Selexid brands; digestive products under the Scheriproct and Hemoproct brand names; and foot health products under the Pevaryl, Nailner, CCS, and wortie brands. The company also provides wellness products under the nutravita, Alpha Foods, Flux, Allévo, and Lactocare brand names; pain, cough, and cold products under the Paracet, Ibux, Mollipect, and Viruseptin brands; and specialty products under the Burinex, Centyl, Kaleorid, and Lithionit brand names. Karo Healthcare AB was formerly known as Karo Pharma AB (publ). The company was incorporated in 1987 and is based in Stockholm, Sweden.

Employees
369
Market
Sweden

Earnings

Latest Release
Sep 21, 2023
EPS / Forecast
-1.26 / 0.06
Revenue / Forecast
2.17B / 1.192B
EPS Revisions
Last 90 days

KARO Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.